May 9 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2025 Mar 31, 2024 Mar 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 5.31 5.06 5.50 2.70
(+4.9 pct) (+2.7 pct) (+3.7 pct) (+1.1 pct)
Operating 823 mln 865 mln 850 mln 400 mln
(-4.8 pct) (+5.4 pct) (+3.2 pct) (-15.1 pct)
Recurring 828 mln 928 mln 850 mln 400 mln
(-10.8 pct) (+8.7 pct) (+2.6 pct) (-15.6 pct)
Net 641 mln 637 mln 600 mln 280 mln
(+0.5 pct) (+12.3 pct) (-6.4 pct) (-19.5 pct)
EPS 152.06 yen 152.26 yen 142.33 yen 66.42 yen
Ann Div 35.00 yen 32.00 yen 32.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 35.00 yen 32.00 yen 32.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T